Fiber Biotech (Shanghai) Co., Ltd. – Trademark Portfolio
Entity Type: 99
Fiber Biotech (Shanghai) Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include CATURE and LIGHTCARE.
Room 1203W, No. 100 Guokang Road,
Yangpu District Shanghai
Showing of trademarks Trademarks
Trademark Classifications
Fiber Biotech (Shanghai) Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Fiber Biotech (Shanghai) Co., Ltd. have?
Fiber Biotech (Shanghai) Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.
What trademark classes does Fiber Biotech (Shanghai) Co., Ltd. file in?
Fiber Biotech (Shanghai) Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are Fiber Biotech (Shanghai) Co., Ltd.'s most well-known trademarks?
Fiber Biotech (Shanghai) Co., Ltd.'s registered trademark portfolio includes well-known marks such as CATURE and LIGHTCARE. These are among 3 currently registered trademarks in the portfolio.
What is Fiber Biotech (Shanghai) Co., Ltd.'s trademark registration success rate?
Fiber Biotech (Shanghai) Co., Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.